$SEM

Davisson Katherine R sold (to issuer) $991K of SEM

Davisson Katherine R sold (to issuer) 60,035 shares of SELECT MEDICAL HOLDINGS CORP (SEM) at $16.50 ($0.99M total) on 2026-06-30.

Original reporting
SEC EDGAR · Davisson Katherine R
Published Jul 1, 2026, 6:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 6:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SEM
Neutral
medium confidence
Mentioned
$SEM
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEMNeutralLow
01

Why it matters

The newest fact is the disclosed insider sale size, price, and post-transaction holdings (0 shares). This can marginally affect sentiment but does not provide new company fundamentals.

02

Market read

Traders may note insider selling at a specific price, but the disclosure is unlikely to drive a durable repricing without accompanying fundamental news.

03

What to watch

No 10b5-1 plan is indicated, but the filing still lacks context on whether the transaction was pre-planned or part of a routine corporate program.

Relevance 5/10Novelty 5/10Timing: Form 4 filed July 1, 2026 (after the June 30 transaction)

Background

The article is an SEC Form 4 insider transaction disclosure for Select Medical Holdings Corp (SEM).

Company-level read

Ticker impact

$SEMNeutralMedium confidence
Context

Select Medical Holdings director Katherine R Davisson sold 60,035 shares to the issuer at $16.50/share for ~$990.6K, per Form 4 filed today.

Expected impact

Low likelihood of a sustained price move; any reaction is likely brief and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider transaction with disclosed size and price, but it does not include new operating, guidance, or regulatory information.

Market effects

Minimal; insider sale does not change sector fundamentals for healthcare services.

None indicated.

None indicated.

Counterpoint

Because the sale is coded as “sale to issuer” (often buyback participation), it may be mechanical rather than a bearish view on the stock.

Key entities

  • SELECT MEDICAL HOLDINGS CORP

    Subject of the Form 4 insider transaction disclosure.

  • Davisson Katherine R

    Director who sold 60,035 shares to the issuer at $16.50/share on June 30, 2026.

Related articles

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.